95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.87%
Revenue growth 1.25-1.5x FNV's 5.33%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
18.63%
Gross profit growth above 1.5x FNV's 3.82%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-2.88%
Negative EBIT growth while FNV is at 0.32%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2.88%
Negative operating income growth while FNV is at 0.37%. Joel Greenblatt would press for urgent turnaround measures.
-15.44%
Negative net income growth while FNV stands at 5.03%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.95%
Negative EPS growth while FNV is at 4.88%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.95%
Negative diluted EPS growth while FNV is at 4.88%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Share reduction more than 1.5x FNV's 0.40%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x FNV's 0.48%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
7.85%
Dividend growth 1.25-1.5x FNV's 5.44%. Bruce Berkowitz would see if management’s capital return strategy is more aggressive yet sustainable.
11.35%
OCF growth at 50-75% of FNV's 20.23%. Martin Whitman would question if the firm lags in monetizing sales effectively.
142.65%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
-35.57%
Negative 10Y revenue/share CAGR while FNV stands at 108.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.69%
Negative 5Y CAGR while FNV stands at 84.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.75%
3Y revenue/share CAGR under 50% of FNV's 21.72%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-46.91%
Negative 10Y OCF/share CAGR while FNV stands at 137.91%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
2.05%
Below 50% of FNV's 113.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
29.22%
3Y OCF/share CAGR at 50-75% of FNV's 48.35%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-26.72%
Negative 10Y net income/share CAGR while FNV is at 470.26%. Joel Greenblatt sees a major red flag in long-term profit erosion.
218.14%
5Y net income/share CAGR at 75-90% of FNV's 266.00%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
112.27%
3Y net income/share CAGR above 1.5x FNV's 42.79%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
69.51%
10Y equity/share CAGR 1.25-1.5x FNV's 51.37%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
34.27%
5Y equity/share CAGR is in line with FNV's 31.60%. Walter Schloss would see parallel mid-term profitability and retention policies.
24.94%
3Y equity/share CAGR similar to FNV's 24.30%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
91.37%
10Y dividend/share CAGR 1.25-1.5x FNV's 61.92%. Bruce Berkowitz confirms if a higher payout growth rate remains sustainable long term.
78.81%
5Y dividend/share CAGR above 1.5x FNV's 46.19%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
77.13%
3Y dividend/share CAGR above 1.5x FNV's 33.82%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
1.34%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-6.70%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.62%
Similar asset growth to FNV's 2.84%. Walter Schloss finds parallel expansions or investment rates.
2.51%
1.25-1.5x FNV's 2.25%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-8.41%
We’re deleveraging while FNV stands at 13.97%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
104.71%
SG&A growth well above FNV's 131.37%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.